Related Experiment Video
Updated: Oct 13, 2025

06:10
Identifying Mutations by High Resolution Melting in a TILLING Population of Rice
Published on: September 2, 2019
7.5K
Rapid screening for mutations associated with malignant hyperthermia using high-resolution melting curve analysis
I-Min Su1, Po-Kai Wang1, Chun-Yu Chen2
1Department of Anesthesiology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Tzu Chi Medical Journal
|November 11, 2021
Summary
High-resolution melting (HRM) analysis effectively screens for malignant hyperthermia (MH) by rapidly identifying RYR1 gene variants. This method offers a promising alternative to invasive testing for predicting MH risk.
Area of Science:
- Genetics
- Molecular Biology
- Anesthesiology
Background:
- Malignant hyperthermia (MH) diagnosis relies on clinical signs or invasive tests like the in vitro contracture test.
- Genetic diagnosis of MH is challenging due to laborious direct mutation screening.
- A rapid and accurate screening tool is needed for MH-associated mutations.
Purpose of the Study:
- To evaluate high-resolution melting (HRM) curve analysis as a rapid screening tool for MH-associated mutations.
- To assess the feasibility of HRM for detecting single-nucleotide variants in the RYR1 gene.
Main Methods:
- Engineered plasmids with wild-type and mutated RYR1 gene sequences were created.
- DNA from MH patients with known genotypes was analyzed.
- Real-time polymerase chain reaction (PCR) and HRM analysis were performed using the LightCycler 480 System.
Main Results:
- HRM analysis showed distinct results compared to real-time PCR.
- HRM provided sufficient resolution to identify single-nucleotide variants in RYR1 exons.
- The method demonstrated effectiveness in discriminating between different RYR1 sequences.
Conclusions:
- HRM analysis is a high-resolution technique for identifying RYR1 single-nucleotide variants.
- HRM may serve as a valuable tool for predicting MH risk in preanesthesia settings.
- This method offers a potentially faster and more accessible approach to MH genetic screening.

